Niacin skin flush in schizophrenia: A preliminary report

Schizophrenia Research

Volumn 29, Issue 3, 1998, Pages 269-274

  Ward, P E ^a   Sutherland, J ^a   Glen, E M T ^a   Glen, A I M ^a  

^a Highland Psychiatric Research Group   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; NICOTINIC ACID; NICOTINIC ACID METHYL ESTER; PROSTAGLANDIN D2; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUSHING; FOREARM; HUMAN; MACROPHAGE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHIZOPHRENIA; SKIN CAPILLARY; SKIN TEST; TIME; TOPICAL DRUG ADMINISTRATION; VASODILATATION;

ADULT; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTE MEMBRANE; FEASIBILITY STUDIES; FEMALE; FLUSHING; HUMANS; MALE; MIDDLE AGED; NICOTINIC ACIDS; PILOT PROJECTS; PROSTAGLANDIN D2; PSYCHIATRIC STATUS RATING SCALES; REFERENCE VALUES; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY; SKIN; VASODILATION;

EID: 0032498525     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(97)00100-X     Document Type: Article

References (19)

1. Di Marzo, V., Piomelli, D., 1992. Participation of prostaglandin E2 in dopamine D2 receptor-dependent potentiation of arachidonic response. J. Neurochem. 59, 379-382.
2. Gattaz, W.F., Schmitt, A., Maras, A., 1995. Increased platelet phospholipase A2 activity in schizophrenia. Schizophr. Res. 16, 1-6.
3. Glen, A.I.M., Glen, E.M.T., Horrobin, D.F., Vaddadi, K.S., Spellman, M., Morse-Fisher, N., Ells, K., Skinner, F.S., 1994. A red cell membrane abnormality in a sub-group of schizophrenic patients: evidence for two diseases. Schizophr. Res. 12, 53-61.
4. Glen, A.I.M., Cooper, S.J., Rybakowski, J. et al., 1996. Membrane fatty acids, niacin flushing and clinical parameters. Prostaglandins, Leukotrienes Essent. Fatty Acids 55, 9-15.
5. Horrobin, D.F., 1977. Schizophrenia as a prostaglandin deficiency disease. Lancet 1, 936-937.
6. Horrobin, D.F., 1980. Niacin flushing, prostaglandin E and evening primrose oil: a possible objective test for monitoring therapy in schizophrenia. Orthomolec. Psychiatry 9, 33-34.
7. Hudson, C.J., Kennedy, J., Lin, A. et al., 1996. Genetic variant near cytosolic Phospholipase A2 associated with schizophrenia. Schizophr. Res. 21, 111-116.
8. Katsuki, H., Okuda, S., 1995. Arachidonic acid as a neurotoxic and neurotrophic substance. Prog. Neurobiol. 46, 607-636.
9. Miller D.R., Hayes K.C., 1982. Niacin. In: Hathcock, J. (Ed.), Nutritional Toxicology, vol. 1. Academic Press, New York, p. 108.
10. Morrow, J.D., Awad, J.A., Oates, J.A., Roberts, L.J., 1992. Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans. J. Invest. Dermatol. 98, 812-815.
11. Murakami, M., Matsumoto, R., Urade, Y. et al., c-Kit ligand mediates increased expression of cytosolic phospholipase A2, prostaglandin endoperoxide synthase-1, and hematopoietic prostaglandin D2 synthase and increased IgE-dependent prostaglandin D2 generation in immature mouse mast cells. 1995. J. Biol. Chem. 270, 3239-3246.
12. Murrell, T.W., Taylor, W.M., 1959. The cutaneous reaction to nicotinic acid (niacin)-furfuryl. Am. Med. Assoc. Arch. Dermatol. 79, 93-98.
13. Nunez, E.A. (Ed.), 1993. Fatty acids and cell signalling. Prostaglandins Leukotrienes Essent. Fatty Acids 48, 1-122.
14. Peet, M., Laugharne, J.D.E., Horrobin, D.F., Reynolds, G.P., 1994. Arachidonic acid: a common link in the biology of schizophrenia? Arch. Gen. Psychiatry 51, 665-666.
15. Pettegrew, J.W., Keshavan, M.S., Panchalingam, K. et al., 1991. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. Arch. Gen. Psychiatry 48, 563-568.
16. Rao, C.V., Sin-ii, B., Wynn, T.-T. et al., Modulating effect of amount and types of dietary fat on colonic mucosal phospholipase A2, phosphatidylinositol-specific phospholipase C activities, and cyclo-oxygenase metabolite formation during different stages of colon tumour promotion in male F344 rats. 1996. Cancer Res. 56, 532-537.
17. Rybakowski, J., Weterle, R., 1991. Niacin test in schizophrenia and affective illness. Biol. Psychiatry 29, 834-836.
18. Tay, A., Squire, J.A., Goldberg, H., Scorecki, K., 1994. Assignment of the human prostaglandin-endoperoxide synthase 2 (PTGS2) gene to lq25 by fluorescence in situ hybridization. Genomics 23, 718-719.
19. Yao, J.K., Van Kammen, D.P., Welker, J.A., 1994. Red cell membrane dynamics in schizophrenia. II: Fatty acid composition. Schizophr. Res. 13, 217-226.